3D4 Pedia: a drug “printed” as close as possible to patients
The collaboration between the laboratories ofthe University of Montpellier (UM) and MB Therapeutics paves the way for a new generation of personalized treatments: thanks to 3D printing technology developed over several years, the 3D4 Pedia project could revolutionize drug treatment for young patients.
A major breakthrough in pediatric medicine, driven by innovation in Montpellier and the expertise of a pioneering industrial player, supported by the Companies and Campus program.
Read the full article: 3D4 Pedia – a drug printed close to patients
co-founder of MB Therapeutics, and head of the drug production unit at Nîmes University Hospital